Rating
Buy
Price target
$252
Previous
$250
Implied upside
+65%

Barclays analyst Raimo Lenschow raised the price target on Oracle (NYSE: ORCL) to $252 (from $250) while maintaining a Overweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Other Oracle notes

BMO CapitalBuy Lowers target · Sep 11, 2026 $195from $220 CantorBuy Reiterate · Sep 11, 2026 $284maintained OppenheimerBuy Reiterate · Sep 11, 2026 $275maintained GuggenheimBuy Reiterate · Sep 11, 2026 $400maintained StifelBuy Lowers target · Sep 11, 2026 $200from $220

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.